These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10599070)

  • 1. [Role of positron emission tomography (PET) and single photon emission tomography (SPECT) in so-called "multiple chemical sensitivity"].
    Bartenstein P; Grünwald F; Herholz K; Kuwert T; Tatsch K; Sabri O; Weiller C
    Nuklearmedizin; 1999; 38(7):297-301. PubMed ID: 10599070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET in patients with clear-cut multiple chemical sensitivity (MCS).
    Bornschein S; Hausteiner C; Drzezga A; Bartenstein P; Schwaiger M; Förstl H; Zilker T
    Nuklearmedizin; 2002 Dec; 41(6):233-9. PubMed ID: 12520659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional brain imaging in the assessment of multiple chemical sensitivities.
    Waxman AD
    Occup Med; 2000; 15(3):611-6. PubMed ID: 10903554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critique: SPECT studies of multiple chemical sensitivity.
    Mayberg H
    Toxicol Ind Health; 1994; 10(4-5):661-6. PubMed ID: 7778121
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotoxicity in single photon emission computed tomography brain scans of patients reporting chemical sensitivities.
    Ross GH; Rea WJ; Johnson AR; Hickey DC; Simon TR
    Toxicol Ind Health; 1999; 15(3-4):415-20. PubMed ID: 10416294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET & SPECT instrumentation.
    Spanoudaki VC; Ziegler SI
    Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
    Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
    Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH; Delbeke D; Patton JA; Sandler MP
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease.
    Go RT; Marwick TH; MacIntyre WJ; Saha GB; Neumann DR; Underwood DA; Simpfendorfer CC
    J Nucl Med; 1990 Dec; 31(12):1899-905. PubMed ID: 2266384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective localization of epileptogenic foci: comparison of PET and SPECT with site of surgery and clinical outcome.
    Mastin ST; Drane WE; Gilmore RL; Helveston WR; Quisling RG; Roper SN; Eikman EA; Browd SR
    Radiology; 1996 May; 199(2):375-80. PubMed ID: 8668781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in instrumentation for emission computed tomography.
    Daube-Witherspoon ME; Zubal IG; Karp JS
    Semin Nucl Med; 2003 Jan; 33(1):28-41. PubMed ID: 12605355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain imaging of an alcoholic with MRI, SPECT, and PET.
    Wang GJ; Volkow ND; Hitzemann R; Oster ZH; Roque C; Cestaro V
    Am J Physiol Imaging; 1992; 7(3-4):194-8. PubMed ID: 1343215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT and PET in the evaluation of coronary artery disease.
    Jadvar H; Strauss HW; Segall GM
    Radiographics; 1999; 19(4):915-26. PubMed ID: 10464799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VECTor: a preclinical imaging system for simultaneous submillimeter SPECT and PET.
    Goorden MC; van der Have F; Kreuger R; Ramakers RM; Vastenhouw B; Burbach JP; Booij J; Molthoff CF; Beekman FJ
    J Nucl Med; 2013 Feb; 54(2):306-12. PubMed ID: 23077113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT.
    Ryvlin P; Philippon B; Cinotti L; Froment JC; Le Bars D; Mauguière F
    Ann Neurol; 1992 Jun; 31(6):650-6. PubMed ID: 1514777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT imaging in psychiatry: introduction and overview.
    Weinberger DR
    J Clin Psychiatry; 1993 Nov; 54 Suppl():3-5. PubMed ID: 8270596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.